Evidence map›Paper›PMID 35478667›Full record

ArticleRSC advances2021

Effective inhibition and eradication of pathogenic biofilms by titanium dioxide nanoparticles synthesized using

Mohammad Altaf, Mohammad Tarique Zeyad, Md Amiruddin Hashmi, Salim Manoharadas, Shaik Althaf Hussain, Mohammed Saeed Ali Abuhasil, Mohammed Abdulaziz M Almuzaini

Abstract read
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Ni-Fe Nanoparticles fromCurrent pharmaceutical design · 2026
    Article
  5. Nanoflowers: Smart Molecules for Biofilm Management.Applied biochemistry and biotechnology · 2025
    Review
  6. Article
  7. Article
  8. Management of virulence inRSC advances · 2023
    Article
  9. Inhibition of Mixed Biofilms ofAntibiotics (Basel, Switzerland) · 2023
    Article
  10. Review
  11. Regulation ofPharmaceutics · 2023
    Review
  12. Review
  13. Article
  14. Article
  15. Benefits of Usage of Immobilized Silver Nanoparticles asInternational journal of molecular sciences · 2021
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mohammad AltafDepartment of Chemistry, College of Science, King Saud University Riyadh 11451 Saudi Arabia.
Mohammad Tarique ZeyadDepartment of Agricultural Microbiology, Faculty of Agricultural Sciences, Aligarh Muslim University Aligarh UP-202002 India mohd.zeyad@gmail.com.ORCID https://orcid.org/0000-0003-0811-4777
Md Amiruddin HashmiInterdisciplinary Biotechnology Unit, Aligarh Muslim University Aligarh UP-202002 India.
Salim ManoharadasCentral Laboratory, College of Science, King Saud University Riyadh 11451 Saudi Arabia.ORCID https://orcid.org/0000-0002-1875-5976
Shaik Althaf HussainCentral Laboratory, College of Science, King Saud University Riyadh 11451 Saudi Arabia.
Mohammed Saeed Ali AbuhasilDepartment of Food Science and Nutrition, College of Food & Agriculture Sciences, King Saud University Riyadh 11451 Saudi Arabia.
Mohammed Abdulaziz M AlmuzainiCentral Laboratory, College of Science, King Saud University Riyadh 11451 Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most bacteria exist in nature in the form of biofilms. One of the key survival strategies by bacteria to withstand chemical and physical stresses is by forming biofilms on biotic and abiotic surfaces. A different set of genes are expressed in biofilms compared to the planktonic mode of bacterial growth. According to data from the National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC), nearly 80 percent of all human infections are encouraged by biofilms and roughly 65 percent of all hospital-acquired infections are associated with biofilms. Hence, considering the role of biofilms in clinical settings, there is an urgent need for the discovery/development of novel antibiofilm agents. In this study, we have tested the effect of freshly prepared titanium dioxide nanoparticles (TiO

Identifiers

PMID35478667
PMCPMC9033554

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.